MorphoSys Financial Statements From 2010 to 2026
MorphoSys' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing MorphoSys' valuation are provided below:MorphoSys AG does not presently have any fundamental ratios for analysis.
This module can also supplement various MorphoSys Technical models . Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
Check MorphoSys financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MorphoSys' main balance sheet or income statement drivers, such as , as well as many indicators such as . MorphoSys financial statements analysis is a perfect complement when working with MorphoSys Valuation or Volatility modules.
MorphoSys |
MorphoSys AG Company Return On Asset Analysis
MorphoSys' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current MorphoSys Return On Asset | -0.0488 |
Most of MorphoSys' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MorphoSys AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, MorphoSys AG has a Return On Asset of -0.0488. This is 99.44% lower than that of the Healthcare sector and 99.79% lower than that of the Biotechnology industry. The return on asset for all United States stocks is 65.14% lower than that of the firm.
MorphoSys AG Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining MorphoSys's current stock value. Our valuation model uses many indicators to compare MorphoSys value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MorphoSys competition to find correlations between indicators driving MorphoSys's intrinsic value. More Info.MorphoSys AG is regarded second in return on equity category among its peers. It also is regarded second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MorphoSys' earnings, one of the primary drivers of an investment's value.Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in MorphoSys Pink Sheet
If you are still planning to invest in MorphoSys AG check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MorphoSys' history and understand the potential risks before investing.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |